Regen BioPharma (RGBP) Stock Price, News & Analysis

Company Overview

Regen BioPharma, Inc. is a biotechnology company focused on developing regenerative medicine and immunotherapy applications. The company has historically described its work as targeting conditions involving bone marrow failure, cancer and immune-system dysfunction.

Its reported research programs have included HemaXellerate, an investigational approach intended to support the restoration of blood-forming cells, as well as programs involving cancer vaccines, immune modulation and the NR2F6 biological pathway. These programs have been presented as research and development initiatives rather than widely marketed commercial products.

Public information about Regen BioPharma’s current operations, commercial reach and leadership is limited and may have changed over time. The company has been associated with David Koos in executive and leadership roles in historical corporate disclosures. Regen BioPharma’s securities trade under the symbol RGBP on the OTC Markets.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.02
• Volume: 3,116 shs
• Average Volume: 16.04 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:RGBP
• CIK: 1589150
• Web: www.regenbiopharmainc.com
• Phone: (619) 722-5505
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A